2025 Flinn Foundation Bio Capital Conference

Managing Growth and VC Capital As You Scale


7:45 a.m.–4:30 p.m.
Networking reception to follow


Thursday, March 6, 2025


Creighton University Health Sciences Campus–Phoenix
3100 N. Central Ave.

The conference, “Managing Growth and VC Capital As You Scale,” brings together investors and the startup community with a specific focus on the biosciences and health tech.  

Registration is $50, which includes a continental breakfast, lunch, and a post-conference reception.

The Flinn Foundation, in collaboration with the Risk Capital Project Team of Arizona’s Bioscience Roadmap Steering Committee, looks forward to seeing you.  

Agenda

Morning Session

Welcome
  • Helen Goldstein, Attorney, Procopio (emcee)
  • Phoenix Mayor Kate Gallego

Keynote
  • A national view of the bioscience/life science funding landscape featuring J.P. Morgan

Fireside Chat
  • Perspective on growth and capital needs as a company scales with Louis Breton, Rampart Bioscience
  • Moderated by Chris Yoo, Ph.D., General Partner, XCellerant Ventures

Panel: The money is in, what’s next?
  • Paul Johnson, Partner, Procopio
  • Moderated by Donald Laughlin, President and CEO, White Mountain Economic Development

Flinn Foundation Bioscience Entrepreneurship Program announcement
  • Tammy McLeod, Ph.D., Flinn Foundation President and CEO

Networking Lunch, Storytelling Workshop


Afternoon Session

Panel: How VC’s assess companies/investments
  • Moderated by Janelle Goulard, Pangaea Ventures

Panel: Growing your team as you scale
  • Moderated by Stan Nowak, HCIT entrepreneur, CEO and investor

Keynote
  • Michael Gorton, founder of Teladoc, shares his insights on managing growth and investor expectations

Reception


Questions 

Contact Mary O’Reilly, Flinn Foundation Vice President, Bioscience Research Programs, at [email protected].



Creighton University Health Sciences Campus–Phoenix
3100 N. Central Ave.
Phoenix

Past Conferences

Thriving in a Challenging Economy 


Risk Capital: Getting to Yes!


Spring into Commercialization